论文部分内容阅读
自1981年3月至1984年9月我科用华蟾素注射液治疗各类晚期肿瘤40例,取得了较好的近期疗效,现报告女如下。临床资料一、性别与年龄:男32例,女8例;年龄最小者28岁,最大者79岁,50岁以上者34例。二、病例选择:本组患者均按统一方案治疗。肝癌患者符合1971年全国抗癌药物经验交流学习班临床诊断标准。其他肿瘤患者经X线、内窥镜、病理或细胞学确诊。凡配合放、化疗者皆不包括在内。三、肿瘤类型:原发性肝癌29例,其中Ⅱ期12例,Ⅲ期17例;胃癌6例;食管癌3例;肺癌2例皆为Ⅲ期或Ⅳ期,多数系手术未能切除或无法接受手术治疗的晚期病人。四、治疗方法:华蟾素注射液每支2毫
From March 1981 to September 1984, our department used Huachansu injection to treat 40 cases of various types of advanced tumors, and achieved good short-term curative effect. The present report is as follows. Clinical data 1. Sex and age: 32 males and 8 females; the youngest 28 years old, the largest 79 years old, 34 years of age over 50. Second, case selection: This group of patients were treated according to a unified plan. Liver cancer patients met the clinical diagnostic criteria of the 1971 national anticancer drug experience exchange class. Other tumor patients were confirmed by X-ray, endoscopy, pathology or cytology. All those who combine with chemotherapy and chemotherapy are not included. 3. Tumor types: 29 cases of primary liver cancer, including 12 in stage II, 17 in stage III, 6 in gastric cancer, 3 in esophageal cancer, and 2 in stage III or IV of lung cancer. Late patients who cannot undergo surgery. IV. Treatment: Huachansu Injection 2 milligrams per